130 related articles for article (PubMed ID: 8927422)
41. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
42. Mucinous differentiation in colonic adenocarcinoma is associated with a reduction in tumour-infiltrating lymphocytes.
Millar EK; Beretov J; Sarris M; Lee CS
Eur J Surg Oncol; 2001 Apr; 27(3):273-7. PubMed ID: 11373104
[TBL] [Abstract][Full Text] [Related]
43. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M
Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathological features of signet-ring cell carcinoma of the colon and rectum: a case-matched study.
Min BS; Kim NK; Ko YT; Baek SH; Lee KY; Sohn SK; Cho CH; Kang DR
Hepatogastroenterology; 2009; 56(93):984-8. PubMed ID: 19760925
[TBL] [Abstract][Full Text] [Related]
45. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
[TBL] [Abstract][Full Text] [Related]
46. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
Purdie CA; Piris J
Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
[TBL] [Abstract][Full Text] [Related]
47. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
48. Treatment outcomes in patients with signet ring cell carcinoma of the colorectum.
Lee WS; Chun HK; Lee WY; Yun SH; Cho YB; Yun HR; Park SH; Song SY
Am J Surg; 2007 Sep; 194(3):294-8. PubMed ID: 17693269
[TBL] [Abstract][Full Text] [Related]
49. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
[TBL] [Abstract][Full Text] [Related]
50. High apoptotic activity and low epithelial cell proliferation with underexpression of p21(WAF1/CIP1) and p27Kip1 of mucinous carcinomas of the colorectum: comparison with well-differentiated type.
Akino F; Mitomi H; Nakamura T; Ohtani Y; Ichinoe M; Okayasu I
Am J Clin Pathol; 2002 Jun; 117(6):908-15. PubMed ID: 12047142
[TBL] [Abstract][Full Text] [Related]
51. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
[TBL] [Abstract][Full Text] [Related]
52. Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis.
Schneider A; Stolte M
Z Gastroenterol; 1993 Mar; 31(3):192-7. PubMed ID: 8386413
[TBL] [Abstract][Full Text] [Related]
53. Mucinous carcinoma of the colon and rectum in Phramongkutklao Hospital.
Chaleoykitti B
J Med Assoc Thai; 2006 Jan; 89(1):25-8. PubMed ID: 16583577
[TBL] [Abstract][Full Text] [Related]
54. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.
Mekenkamp LJ; Heesterbeek KJ; Koopman M; Tol J; Teerenstra S; Venderbosch S; Punt CJ; Nagtegaal ID
Eur J Cancer; 2012 Mar; 48(4):501-9. PubMed ID: 22226571
[TBL] [Abstract][Full Text] [Related]
55. Mucinous differentiation in colorectal cancer--indicator of poor prognosis?
Langner C; Harbaum L; Pollheimer MJ; Kornprat P; Lindtner RA; Schlemmer A; Vieth M; Rehak P
Histopathology; 2012 Jun; 60(7):1060-72. PubMed ID: 22348346
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody Ki-67. Relation to clinical and pathological variables.
Lanza G; Cavazzini L; Borghi L; Ferretti S; Buccoliero F; Rubbini M
Pathol Res Pract; 1990 Oct; 186(5):608-18. PubMed ID: 2287588
[TBL] [Abstract][Full Text] [Related]
57. Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum.
Zhang H; Evertsson S; Sun X
Int J Oncol; 1999 Jun; 14(6):1057-61. PubMed ID: 10339657
[TBL] [Abstract][Full Text] [Related]
58. Mucinous adenocarcinoma of the colon - a histochemical study.
Ionilă M; Mărgăritescu C; Pirici D; Mogoantă SS
Rom J Morphol Embryol; 2011; 52(3):783-90. PubMed ID: 21892519
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathologic features of colorectal carcinoma: features predicting higher T-stage and nodal metastasis.
Hashmi AA; Hashmi SK; Ali N; Thara K; Ali R; Edhi MM; Faridi N; Khan A
BMC Res Notes; 2018 Jan; 11(1):52. PubMed ID: 29351808
[TBL] [Abstract][Full Text] [Related]
60. Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma.
Sekine S; Ogawa R; Oshiro T; Kanemitsu Y; Taniguchi H; Kushima R; Kanai Y
Genes Chromosomes Cancer; 2014 Apr; 53(4):366-72. PubMed ID: 24470207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
